Related Experiment Videos
[Cardiovascular risk and management of patients with hypertension]
I Colombet1, G Chatellier, M C Jaulent
1SPIM (Santé publique et informatique médicale), 15, rue de l'école de Médecine, 75270 Paris.
Insights
Cardiovascular disease prevention strategies face challenges despite evidence favoring risk estimation. This article explores issues in validating risk equations, physician/patient perception, and practical implementation for better hypertension management.
Area of Science:
- Cardiology
- Preventive Medicine
- Health Services Research
Context:
- Cardiovascular diseases (CVDs) are a leading preventable health concern.
- Hypertension and other risk factors remain inadequately controlled globally.
- Current prevention strategies require enhanced tools for targeted interventions.
Purpose:
- To summarize the challenges and considerations for implementing cardiovascular risk-based prevention strategies.
- To highlight the need for robust validation and effective communication of risk assessment tools.
- To discuss practical aspects of applying risk estimation in clinical settings.
Summary:
- Evidence supports CVD prevention through risk estimation, but practical implementation faces hurdles.
- Key challenges include validating risk prediction equations for accuracy and transportability.
- Physician and patient perception of risk, decisional thresholds, and presentation methods (e.g., computerization) are critical factors.
Impact:
- Improved targeting of high-risk patients for cardiovascular disease prevention.
- Enhanced understanding of the complexities in applying risk assessment tools in clinical practice.
- Informing the development of more effective and user-friendly CVD prevention guidelines and technologies.
Abstract:
Whereas cardiovascular diseases remain a priority amongst preventable diseases and that their risk factors, especially hypertension, remain inadequately controlled, new tools, such as the cardiovascular risk, would allow better targeting of treatment on high risk patients. All the evidence is in favour of prevention based on the estimation of the risk, but this article summarises the problems which this strategy continues to pose. In particular, necessity of validation at several levels of the equation or equations used (exactitude of the estimated risk, its accuracy and transportability); influence of the mode of presentation of the risk on the perception and decision of the physician and patient; practical application of the strategy; choice of decisional threshold respecting the requirements of different age groups, and presentation to physicians (recommendations and/or computerisation?).